Literature DB >> 18042325

The importance of risk factor reduction in erectile dysfunction.

Graham Jackson1.   

Abstract

Erectile dysfunction (ED) is associated with modifiable risk factors. Obesity, physical inactivity, and the metabolic syndrome increase the incidence of ED and markers of low-grade inflammation, which in turn are associated with endothelial dysfunction. Intensive intervention with lifestyle advice focusing on a healthy diet, weight loss, and increased physical activity benefits men with ED, reducing the markers of inflammation and improving endothelial function. Though phosphodiesterase type 5 inhibitors are highly effective in treating ED, lifestyle advice and aggressive risk reduction remain fundamental to the overall vascular good health of the individual.

Entities:  

Mesh:

Year:  2007        PMID: 18042325     DOI: 10.1007/s11934-007-0049-x

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   2.862


  27 in total

1.  Cardiovascular risk factors determine erectile and arterial function response to sildenafil.

Authors:  Hemant Solomon; Anthony S Wierzbicki; Peter J Lumb; Michelle Lambert-Hammill; Graham Jackson
Journal:  Am J Hypertens       Date:  2006-09       Impact factor: 2.689

2.  Erectile dysfunction as a predictor of the metabolic syndrome in aging men: results from the Massachusetts Male Aging Study.

Authors:  Varant Kupelian; Ridwan Shabsigh; Andre B Araujo; Amy B O'Donnell; John B McKinlay
Journal:  J Urol       Date:  2006-07       Impact factor: 7.450

3.  The metabolic syndrome and erectile dysfunction: multiple vascular risk factors and hypogonadism.

Authors:  Graham Jackson
Journal:  Eur Urol       Date:  2006-03-31       Impact factor: 20.096

4.  Erectile dysfunction: a marker of silent coronary artery disease.

Authors:  Graham Jackson
Journal:  Eur Heart J       Date:  2006-07-19       Impact factor: 29.983

Review 5.  Hypogonadism and metabolic syndrome: implications for testosterone therapy.

Authors:  Nawras Makhsida; Jay Shah; Grace Yan; Harry Fisch; Ridwan Shabsigh
Journal:  J Urol       Date:  2005-09       Impact factor: 7.450

6.  C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

Authors:  J S Yudkin; C D Stehouwer; J J Emeis; S W Coppack
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-04       Impact factor: 8.311

7.  Erectile dysfunction and statin treatment in high cardiovascular risk patients.

Authors:  H Solomon; Y P Samarasinghe; M D Feher; J Man; H Rivas-Toro; P J Lumb; A S Wierzbicki; G Jackson
Journal:  Int J Clin Pract       Date:  2006-02       Impact factor: 2.503

Review 8.  The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine.

Authors:  Graham Jackson; Raymond C Rosen; Robert A Kloner; John B Kostis
Journal:  J Sex Med       Date:  2006-01       Impact factor: 3.802

9.  Men treated with hypolipidaemic drugs complain more frequently of erectile dysfunction.

Authors:  E Bruckert; P Giral; H M Heshmati; G Turpin
Journal:  J Clin Pharm Ther       Date:  1996-04       Impact factor: 2.512

10.  Can atorvastatin improve the response to sildenafil in men with erectile dysfunction not initially responsive to sildenafil? Hypothesis and pilot trial results.

Authors:  Howard C Herrmann; Laurence A Levine; Joseph Macaluso; Michelle Walsh; Danielle Bradbury; Stanley Schwartz; Emile R Mohler; Stephen E Kimmel
Journal:  J Sex Med       Date:  2006-03       Impact factor: 3.802

View more
  8 in total

1.  Erectile dysfunction in stroke patients: a multifactorial problem with important psychosocial consequences.

Authors:  Kosmas I Paraskevas; Nikolaos Bessias; Polyvios Pavlidis; Dimitrios Maras; Theofanis T Papas; Christos D Gekas; Vassilios Andrikopoulos
Journal:  Int Urol Nephrol       Date:  2008-08-06       Impact factor: 2.370

Review 2.  Erectile dysfunction in general medicine.

Authors:  Paul Grant; Graham Jackson; Irfan Baig; John Quin
Journal:  Clin Med (Lond)       Date:  2013-04       Impact factor: 2.659

Review 3.  Sexual dysfunction in patients with alcohol and opioid dependence.

Authors:  Sandeep Grover; Surendra K Mattoo; Shreyas Pendharkar; Venkatesh Kandappan
Journal:  Indian J Psychol Med       Date:  2014-10

4.  The Pol-e-pill finally arrives.

Authors:  James A Levine; Ronald M Davis
Journal:  Diabetes       Date:  2008-07       Impact factor: 9.461

Review 5.  Erectile dysfunction and cardiovascular disease.

Authors:  Graham Jackson
Journal:  Arab J Urol       Date:  2013-05-03

6.  Cardiometabolic risk factors in patients with erectile dysfunction.

Authors:  Serhat Tanik; Savas Sarikaya; Kürşad Zengin; Sebahattin Albayrak; Yunus Keser Yilmaz; Lutfi Akyol
Journal:  ScientificWorldJournal       Date:  2014-01-22

Review 7.  Modifying Risk Factors in the Management of Erectile Dysfunction: A Review.

Authors:  Kenneth J DeLay; Nora Haney; Wayne Jg Hellstrom
Journal:  World J Mens Health       Date:  2016-08-23       Impact factor: 5.400

8.  Association between coronary heart disease and erectile dysfunction in Chinese Han population.

Authors:  Guo-Xiang Tian; Sheng Li; Tong-Zu Liu; Xian-Tao Zeng; Wan-Lin Wei; Xing-Huan Wang
Journal:  Oncotarget       Date:  2017-02-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.